12
Participants
Start Date
July 1, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
second allogeneic stem cell transplantation
"1. Change another donor if possible~2. Conditioning regimen: fludarabine (30mg/m2/day, days -6 to -2 )/cyclophosphamide (1g/m2/day, days -5 to -4)/rabbit antithymocyte globulin (1.5mg/kg/day, days -4 to -2)~3. GVHD prophylaxis: cyclosporine A (concentration 150-250ng/ml), mycophenolate mofetil (0.5g bid -3d to neutrophil engraftment)+anti CD25 monoAb (20mg, +1d, +8d, +15d)"
RECRUITING
Peking University People's Hospital, Beijing
Peking University People's Hospital
OTHER